Stocks in play: Canopy Growth Corporation
Today announced its financial results for the fourth quarter and fiscal year ended March 31, 2024. Canada cannabis net revenue in Q4 FY2024 increased 4% as compared to Q4 FY2023 led by a 16% increase in the Canada medical cannabis business. Operating loss from continuing operations of $229 MM in FY2024. Adjusted EBITDA loss was $59 MM in FY2024, representing an improvement of 72% year-over-year,Canopy Growth Corporation shares T.WEED are trading $1.48 at $13.07.
Read:
Rising Agricultural Markets: Precision Farming and Biotech Propel Growth to $94.23 Billion by 2024
AI in Advertising: From $370 Billion to $1.3 Trillion, The Rapid Rise of Tech-Driven Marketing
Data Center Investments Surge 200% Since 2016, Expected to Grow 89% by 2028 Amid AI Boom
Advancements in Cancer Therapeutics: What to Expect from the Upcoming 2024 Oncology Conference
AI's Energy Challenge: Tech Giants Innovate to Preserve Global Electricity Grids